Feasibility of neoadjuvant chemotherapy for bulky early stage to stage IIIB cervical cancer in Uganda
In this limited-resource setting, majority of patients completed a NAC treatment strategy for cervical cancer with acceptable toxicities.
Authors
- Josephine Irene Najjemba
- Stefanie Ueda (ORCID: https://orcid.org/0000-0002-4359-0966)
- Paula S. Lee (ORCID: https://orcid.org/0000-0003-3524-0058)
- Jane Namugga
- Judith Ajeani
- Anthony Okoth
- Carolyn Nakisige (ORCID: https://orcid.org/0000-0002-1497-8056)
- Janice Wong (ORCID: https://orcid.org/0000-0002-4407-9182)
Institutions
- University of Hawaii System (US)
- University of California, San Francisco (US)
- University of Hawaii–West Oahu (US)
- Mulago Hospital (UG)
- Uganda Cancer Institute (UG)
- Duke University Hospital (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1016/j.gore.2024.101533
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Department of Obstetrics and Gynecology, University of Wisconsin-Madison
- Duke Cancer Institute